Current status and progress in diagnosis and treatment of intrahepatic cholangiocarcinoma
10.3760/cma.j.cn115396-20200408-00093
- VernacularTitle:肝内胆管细胞癌的诊治现状及进展
- Author:
Guangyang SUN
1
;
Hao WANG
;
Dousheng BAI
Author Information
1. 扬州大学医学院 225009
- From:
International Journal of Surgery
2020;47(6):406-411
- CountryChina
- Language:Chinese
-
Abstract:
Intrahepatic cholangiocarcinoma is a malignant tumor that originates from the bile duct above the confluence of left and right hepatic ducts, and is one of the commonest types of primary liver cancer. The early symptoms of intrahepatic cholangiocarcinoma are not obvious, most patients with non-specific abdominal symptoms in the advanced stage. CT, MRI, etc. are helpful for diagnosis, but most patients are in advanced stage when they are diagnosed. Hepatectomy is the main treatment, radiotherapy, chemotherapy are significant adjuvant treatment, and the overall prognosis is poor. This article reviews the current status and progress in diagnosis and treatment of intrahepatic cholangiocarcinoma.
